GlassScriptPhysician profile
Sara Beeler
NPI 1720328198
$337,477.83
in general payments reported to CMS, 2019-2025
75 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Oncology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $263).
See the full distribution for Oncology (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44K · 2022: $70K · 2023: $64K · 2024: $99K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $176K · Food and Beverage: $21K · Travel and Lodging: $18K · Consulting Fee: $6,880 · Long Term Medical Supply Or Device Loan: $882 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $176,400.00 |
| Food and Beverage | $21,316.43 |
| Travel and Lodging | $18,133.14 |
| Consulting Fee | $6,880.00 |
| Long Term Medical Supply Or Device Loan | $882.41 |
| Education | $110.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $266,212.58 | 2021-2025 | Lynparza, Enhertu, Imfinzi |
| Daiichi Sankyo INC. | $54,568.03 | 2021-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $2,653.63 | 2022-2025 | Piqray, Kisqali |
| Janssen Biotech, INC. | $1,076.92 | 2021-2025 | Erleada, Rybrevant, Darzalex |
| E.R. Squibb & Sons, L.L.C. | $1,038.61 | 2021-2025 | Opdivo, Opdualag, Eliquis |
| Gilead Sciences, INC. | $931.24 | 2022-2025 | Trodelvy |
| Celgene Corporation | $896.19 | 2022-2025 | Reblozyl, Pomalyst, Breyanzi |
| Pfizer INC. | $796.97 | 2022-2025 | |
| Incyte Corporation | $684.34 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Merck Sharp & Dohme LLC | $664.35 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Lilly USA, LLC | $495.49 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $468.74 | 2021-2025 | |
| Eisai INC. | $367.41 | 2021-2025 | |
| Glaxosmithkline, LLC. | $352.94 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Regeneron Healthcare Solutions, INC. | $345.70 | 2022-2025 | Libtayo |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $331.06 | 2021-2025 | Vyloy, Xospata, Padcev |
| Puma Biotechnology, INC. | $315.64 | 2021-2025 | |
| Seagen INC. | $296.20 | 2021-2023 | Tukysa, Padcev, Tivdak |
| Bayer Healthcare Pharmaceuticals INC. | $294.42 | 2021-2025 | |
| Genzyme Corporation | $277.29 | 2021-2025 | |
| Amgen INC. | $276.88 | 2021-2023 | Vectibix, Nplate, Xgeva |
| Takeda Pharmaceuticals U.S.A., INC. | $272.52 | 2023-2025 | Fruzaqla, Alunbrig, Hyqvia |
| Tersera Therapeutics LLC | $249.23 | 2024-2025 | Zoladex |
| Pharmacyclics LLC, An Abbvie Company | $236.70 | 2021-2023 | Imbruvica, Epkinly |
| Kite Pharma, INC. | $199.15 | 2022-2025 | Yescarta |
| Beigene USA, INC. | $151.61 | 2023-2024 | Brukinsa, Tevimbra |
| Exelixis INC. | $147.39 | 2021-2025 | Cabometyx |
| Deciphera Pharmaceuticals INC. | $145.92 | 2021-2025 | Qinlock, Romvimza |
| Sumitomo Pharma America, INC. | $136.44 | 2023-2025 | Orgovyx |
| Stemline Therapeutics INC. | $129.19 | 2023-2025 | Orserdu |
| Dendreon Pharmaceuticals LLC | $129.03 | 2023-2025 | Provenge |
| Taiho Oncology, INC. | $118.37 | 2022-2025 | |
| Pharmaessentia USA Corporation | $118.20 | 2023-2025 | Besremi |
| Rigel Pharmaceuticals, INC. | $113.01 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Legend Biotech USA INC. | $111.43 | 2024-2025 | Carvykti |
| Karyopharm Therapeutics INC. | $108.41 | 2022-2025 | Xpovio |
| Genentech USA, INC. | $103.81 | 2022-2025 | Tecentriq, Polivy, Alecensa |
| Pharmacosmos Therapeutics INC. | $98.08 | 2023-2025 | Monoferric, Cosela |
| Aveo Pharmaceuticals, INC. | $97.77 | 2022-2025 | Fotivda |
| Mirati Therapeutics, INC. | $92.35 | 2023-2024 | Krazati |
| Emd Serono, INC. | $87.53 | 2022-2025 | Bavencio |
| Genmab U.S., INC. | $85.35 | 2024-2025 | Epkinly |
| Sobi, INC | $78.58 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $77.51 | 2022-2024 | Onivyde, Somatuline Depot |
| Jazz Pharmaceuticals INC. | $76.00 | 2023-2025 | |
| Blueprint Medicines Corporation | $66.80 | 2021-2025 | Ayvakit |
| Boston Scientific Corporation | $64.71 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Geron Corporation | $63.33 | 2024-2025 | Rytelo |
| Array Biopharma INC | $59.38 | 2023-2025 | Braftovi, Mektovi, Tukysa |
| Myriad Genetic Laboratories, INC. | $51.69 | 2024 | Myrisk |
| Cti Biopharma Corp. | $42.48 | 2023 | Vonjo |
| Agios Pharmaceuticals, INC. | $38.36 | 2023-2025 | Pyrukynd |
| Ge Healthcare | $36.38 | 2022 | |
| G1 Therapeutics, INC. | $36.34 | 2022-2023 | Cosela |
| Csl Behring | $36.28 | 2022-2023 | Afstyla, Idelvion |
| Alexion Pharmaceuticals, INC. | $33.73 | 2024-2025 | Ultomiris |
| Adc Therapeutics America, INC. | $33.49 | 2025 | |
| Myovant Sciences INC. | $31.65 | 2022 | |
| Recordati_rare_diseases_inc. | $30.22 | 2023-2024 | Sylvant |
| Immunocore Limited | $29.24 | 2025 | Kimmtrak |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.22 | 2022 | |
| Tg Therapeutics, INC. | $28.89 | 2022 | |
| Kyowa Kirin, INC. | $28.58 | 2022-2024 | Poteligeo |
| Springworks Therapeutics, INC. | $27.74 | 2024 | Ogsiveo |
| Sun Pharmaceutical Industries INC. | $25.86 | 2024 | |
| Telix Pharmaceuticals | $24.57 | 2023 | Illuccix |
| Syndax Pharmaceuticals, INC. | $21.86 | 2025 | |
| Alnylam Pharmaceuticals INC. | $21.37 | 2022 | |
| Heron Therapeutics, INC. | $21.32 | 2022 | |
| Morphosys, US INC. | $16.04 | 2023 | Monjuvi |
| Foundation Medicine, INC. | $14.52 | 2023 | |
| Shield Therapeutics INC | $14.21 | 2024 | |
| Beone Medicines USA, INC. | $14.11 | 2025 | Brukinsa |
| Acrotech Biopharma INC. | $13.72 | 2022 | |
| Global Blood Therapeutics, INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Beeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.